Embecta News

Embecta Raised to Buy From Neutral by BTIG

Dow JonesNov 27 20:42

Embecta Price Target Announced at $26.00/Share by BTIG

Dow JonesNov 27 20:42

Embecta Analyst Ratings

BenzingaNov 27 20:33

Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Maintains Target Price $13

Futu NewsNov 27 19:32

BTIG Upgrades Embecta(EMBC.US) to Buy Rating, Announces Target Price $26

Futu NewsNov 27 19:31

Embecta Corporation: Discontinued Patch Pump Program and Financial Shortfalls Prompt Sell Rating

TipRanksNov 27 19:18

Embecta Corporation's Strategic Shifts and Revenue Outlook Prompt 'Sell' Rating

TipRanksNov 27 18:50

Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Maintains Target Price $13

Futu NewsSep 6 18:31

BTIG Maintains Embecta(EMBC.US) With Hold Rating

Futu NewsSep 4 20:33

BTIG Reaffirms Their Hold Rating on Embecta Corporation (EMBC)

TipRanksSep 4 20:22

Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Raises Target Price to $13

Futu NewsSep 4 18:31

Recommendation to Sell: Anticipated Costs and Competition Challenge Embecta's New Pump Program

TipRanksSep 4 18:09

Analysts Conflicted on These Healthcare Names: Healthequity (HQY) and Embecta Corporation (EMBC)

TipRanksJul 22 08:18

BTIG Remains a Hold on Embecta Corporation (EMBC)

TipRanksJul 22 08:05

Embecta Analyst Ratings

BenzingaJul 16 01:42

Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $12

BenzingaJul 16 01:42

Morgan Stanley Lowers Price Target on Embecta to $12 From $13, Maintains Underweight Rating

MT NewswiresJul 15 18:47

Damo: Maintaining the Embecta (EMBC.US) rating, adjusted from reduced holdings to reduced holdings rating, and adjusted the target price from $16.00 to $13.00.

Zhitong FinanceMay 10 23:40

Embecta Analyst Ratings

BenzingaMay 10 23:40

Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)

TipRanksApr 1 19:35